A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock

• Published in: Critical care medicine Vol. 44; no. 1; p. 23
• Main Authors: He, Xinrong, Su, Fuhong, Taccone, Fabio Silvio, Laporte, Régent, Kjølbye, Anne Louise, Zhang, Jing, Xie, Keliang, Moussa, Mouhamed Djahoum, Reinheimer, Torsten Michael, Vincent, Jean-Louis
• Format: Journal Article
• Language: English
• Published: United States 01.01.2016
• Subjects: Animals; Arginine Vasopressin - therapeutic use; Female; Norepinephrine - therapeutic use; Random Allocation; Receptors, Vasopressin - agonists; Sheep; Sheep Diseases - drug therapy; Shock, Septic - drug therapy; Shock, Septic - veterinary; Vasoconstrictor Agents - therapeutic use; Vasopressins - therapeutic use
• ISSN: 1530-0293
• DOI: 10.1097/CCM.0000000000001380

Selective vasopressin V(1A) receptor agonists may have advantages over arginine vasopressin in the treatment of septic shock. We compared the effects of selepressin, a selective V(1A) receptor agonist, arginine vasopressin, and norepinephrine on hemodynamics, organ function, and survival in an ovine septic shock model. Randomized animal study. University hospital animal research laboratory. Forty-six adult female sheep. Fecal peritonitis was induced in the anesthetized, mechanically ventilated, fluid-resuscitated sheep, and they were randomized in two successive phases. Three late-intervention groups (each n = 6) received IV selepressin (1 pmol/kg/min), arginine vasopressin (0.25 pmol [0.1 mU]/kg/min), or norepinephrine (3 nmol [0.5 μg]/kg/min) when mean arterial pressure remained less than 70 mm Hg despite fluid challenge; study drugs were thereafter titrated to keep mean arterial pressure at 70-80 mm Hg. Three early-intervention groups (each n = 7) received selepressin, arginine vasopressin, or norepinephrine at the same initial infusion rates as for the late intervention, but already when mean arterial pressure had decreased by 10% from baseline; doses were then titrated as for the late intervention. A control group (n = 7) received saline. All animals were observed until death or for a maximum of 30 hours. In addition to hemodynamic and organ function assessment, plasma interleukin-6 and nitrite/nitrate levels were measured. In the late-intervention groups, selepressin delayed the decrease in mean arterial pressure and was associated with lower lung wet/dry weight ratios than in the other two groups. In the early-intervention groups, selepressin maintained mean arterial pressure and cardiac index better than arginine vasopressin or norepinephrine, slowed the increase in blood lactate levels, and was associated with less lung edema, lower cumulative fluid balance, and lower interleukin-6 and nitrite/nitrate levels. Selepressin-treated animals survived longer than the other animals. In this clinically relevant model, selepressin, a selective V(1A) receptor agonist, was superior to arginine vasopressin and to norepinephrine in the treatment of septic shock, especially when administered early.